Direct Medical Cost of Managing Deep Vein Thrombosis According to the Occurrence of Complications

Author： O'Brien J.A.   Caro J.J.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.20, Iss.9, 2002-09, pp. : 603-615

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A single dose of enoxaparin sodium prevented the occurrence of deep vein thrombosis

By  

Inpharma, Vol. 1, Iss. 1315, 2001-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Treatment options for deep vein thrombosis

By Squizzato Alessandro   Dentali Francesco   Ageno Walter  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 7, 2010-05 ,pp. : 1069-1075

Informa Healthcare

Access to resources Recommend Favorite

Cost Effectiveness of Tinzaparin Sodium Versus Unfractionated Heparin in the Treatment of Proximal Deep Vein Thrombosis

By Caro J.J.  

PharmacoEconomics, Vol. 20, Iss. 9, 2002-09 ,pp. : 593-602

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of a Low-Molecular-Weight Heparin in Prolonged Prophylaxis Against Deep Vein Thrombosis After Total Hip Replacement

By Detournay B.  

PharmacoEconomics, Vol. 13, Iss. 1 Part 2, 1998-01 ,pp. : 81-89

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Bemiparin Sodium versus Unfractionated Heparin and Oral Anticoagulants in the Acute and Long-Term Treatment of Deep Vein Thrombosis

By Gómez-Outes Antonio  

PharmacoEconomics, Vol. 24, Iss. 1, 2006-01 ,pp. : 81-92

Adis International

Access to resources Recommend Favorite